20250228869. Benzodiazepine Pyrazolo Carboxamid (Pfizer .)
Benzodiazepine Pyrazolo Carboxamides as N-protein Inhibitors
Abstract: the invention relates to benzodiazepine pyrazolo carboxamides and pharmaceutically acceptable salts thereof as defined in the description; to their use in medicine; to compositions containing them; to processes for their preparation; and to intermediates used in such processes. the compounds of invention inhibit the activity rsv n-proteins and may be useful in the treatment, prevention, suppression, and amelioration of viral infections such as rsv.
Inventor(s): Jan Antoinette Cusi Romero Adams, Samit Kumar Bhattacharya, Matthew Jeremy Barrett, Alexandre Francois Bedernjak, George Stuart Cockerill, James Arthur Dudley Good, Amit Kalgutkar, Raman Sharma, Joseph Tillotson
CPC Classification: A61K31/5513 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms ; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles ; soap compositions ))
Search for rejections for patent application number 20250228869
- Patent Applications
- Pfizer Inc.
- CPC A61K31/5513
- Jan Antoinette Cusi Romero Adams of Arlington MA US
- Samit Kumar Bhattacharya of Waltham MA US
- Matthew Jeremy Barrett of Darlington GB
- Alexandre Francois Bedernjak of Sedgefield GB
- George Stuart Cockerill of Richmond GB
- James Arthur Dudley Good of Barcelona ES
- Amit Kalgutkar of Waltham MA US
- Raman Sharma of Groton CT US
- Joseph Tillotson of Norwood MA US